Infantile Severe Myoclonic Epilepsy: Disease Bioinformatics
Epilepsy is defined as a diverse set of neurological disorders characterized by seizures. These seizures occur due to abnormal electrical activity in the brain. Factors that may lead to epilepsy include, but are not limited to, brain trauma, gene mutations, strokes, brain cancer, and extensive drug and alcohol use. Seizures occur due to a large release of glutamate, which causes a spread of excitation throughout the brain, which propagates the electrical signal and can lead to neuronal death. Myoclonic infantile epilepsy is characterized by seizures that contain rapid, jerk-like movements that can affect the face and limbs. Myoclonic seizures occur during wakefulness. In infants, myoclonic seizures can be caused by include brain malformations, inborn errors of metabolism, and neurogenetic disorders. The severity of the seizures can vary, and the severe episodes can lead to the child falling and undergoing violent convulsions. About 50 million people have epilepsy, with 80% of that population located in developing countries. It is possible to control epilepsy with medicine, but many cases may require surgery in order to relieve symptoms.
Top Research Reagents
We have 582 products for the study of Infantile Severe Myoclonic Epilepsy that can be applied to Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.
Infantile Severe Myoclonic Epilepsy is also known as Dravet Syndrome, Dravet Syndromes, Severe Infantile Myoclonic Epilepsy, Severe Myoclonic Epilepsy In Infancy, Severe Myoclonic Epilepsy Of Infancy.